ReviewFrontiers in immunology2020

Targeting Hypoxia-A2A Adenosinergic Immunosuppression of Antitumor T Cells During Cancer Immunotherapy.

Joseph M Steingold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.